BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 24837507)

  • 1. Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice.
    Wen Y; Monroe J; Linton C; Archer J; Beard CW; Barnett SW; Palladino G; Mason PW; Carfi A; Lilja AE
    Vaccine; 2014 Jun; 32(30):3796-804. PubMed ID: 24837507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies.
    Loomis RJ; Lilja AE; Monroe J; Balabanis KA; Brito LA; Palladino G; Franti M; Mandl CW; Barnett SW; Mason PW
    Vaccine; 2013 Jan; 31(6):919-26. PubMed ID: 23246547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.
    Wussow F; Chiuppesi F; Martinez J; Campo J; Johnson E; Flechsig C; Newell M; Tran E; Ortiz J; La Rosa C; Herrmann A; Longmate J; Chakraborty R; Barry PA; Diamond DJ
    PLoS Pathog; 2014 Nov; 10(11):e1004524. PubMed ID: 25412505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dense Bodies of a gH/gL/UL128/UL130/UL131 Pentamer-Repaired Towne Strain of Human Cytomegalovirus Induce an Enhanced Neutralizing Antibody Response.
    Lehmann C; Falk JJ; Büscher N; Penner I; Zimmermann C; Gogesch P; Sinzger C; Plachter B
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
    Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
    J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells.
    McVoy MA; Lee R; Saccoccio FM; Hartikka J; Smith LR; Mahajan R; Wang JB; Cui X; Adler SP
    Vaccine; 2015 Dec; 33(51):7328-7336. PubMed ID: 26597035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine.
    Freed DC; Tang Q; Tang A; Li F; He X; Huang Z; Meng W; Xia L; Finnefrock AC; Durr E; Espeseth AS; Casimiro DR; Zhang N; Shiver JW; Wang D; An Z; Fu TM
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):E4997-5005. PubMed ID: 24297878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus.
    Fu TM; Wang D; Freed DC; Tang A; Li F; He X; Cole S; Dubey S; Finnefrock AC; ter Meulen J; Shiver JW; Casimiro DR
    Vaccine; 2012 Dec; 30(52):7469-74. PubMed ID: 23107592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.
    Chiuppesi F; Wussow F; Johnson E; Bian C; Zhuo M; Rajakumar A; Barry PA; Britt WJ; Chakraborty R; Diamond DJ
    J Virol; 2015 Dec; 89(23):11884-98. PubMed ID: 26378171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and biochemical studies of HCMV gH/gL/gO and Pentamer reveal mutually exclusive cell entry complexes.
    Ciferri C; Chandramouli S; Donnarumma D; Nikitin PA; Cianfrocco MA; Gerrein R; Feire AL; Barnett SW; Lilja AE; Rappuoli R; Norais N; Settembre EC; Carfi A
    Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1767-72. PubMed ID: 25624487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies.
    Ai Y; Wu C; Zhang M; Jaijyan DK; Liu T; Zan L; Li N; Yu W; Wang Y; Yuan X; Li C; Zheng W; Zhu H; Liao HX
    Microbiol Spectr; 2022 Dec; 10(6):e0139322. PubMed ID: 36342276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Continuous Neutralizing Epitope within UL128 of Human Cytomegalovirus.
    Chiuppesi F; Kaltcheva T; Meng Z; Barry PA; Diamond DJ; Wussow F
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections.
    Genini E; Percivalle E; Sarasini A; Revello MG; Baldanti F; Gerna G
    J Clin Virol; 2011 Oct; 52(2):113-8. PubMed ID: 21820353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the human cytomegalovirus pentamer complex for vaccine use in a CHO system.
    Hofmann I; Wen Y; Ciferri C; Schulze A; Fühner V; Leong M; Gerber A; Gerrein R; Nandi A; Lilja AE; Carfi A; Laux H
    Biotechnol Bioeng; 2015 Dec; 112(12):2505-15. PubMed ID: 26058896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies.
    Kabanova A; Perez L; Lilleri D; Marcandalli J; Agatic G; Becattini S; Preite S; Fuschillo D; Percivalle E; Sallusto F; Gerna G; Corti D; Lanzavecchia A
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):17965-70. PubMed ID: 25453106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
    Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Human Cytomegalovirus gH/gL/pUL128-131 Pentameric Complex, but Not gH/gL, Inhibits Viral Entry to Epithelial Cells and Presents Dominant Native Neutralizing Epitopes.
    Loughney JW; Rustandi RR; Wang D; Troutman MC; Dick LW; Li G; Liu Z; Li F; Freed DC; Price CE; Hoang VM; Culp TD; DePhillips PA; Fu TM; Ha S
    J Biol Chem; 2015 Jun; 290(26):15985-95. PubMed ID: 25947373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.
    Schneider-Ohrum K; Cayatte C; Liu Y; Wang Z; Irrinki A; Cataniag F; Nguyen N; Lambert S; Liu H; Aslam S; Duke G; McCarthy MP; McCormick L
    J Virol; 2016 Nov; 90(22):10133-10144. PubMed ID: 27581989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates.
    Shen S; Wang S; Britt WJ; Lu S
    Vaccine; 2007 Apr; 25(17):3319-27. PubMed ID: 17287056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human Antibodies.
    Ciferri C; Chandramouli S; Leitner A; Donnarumma D; Cianfrocco MA; Gerrein R; Friedrich K; Aggarwal Y; Palladino G; Aebersold R; Norais N; Settembre EC; Carfi A
    PLoS Pathog; 2015 Oct; 11(10):e1005230. PubMed ID: 26485028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.